drugset / Trial / NCT01190722

A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain

NCT01190722

Phase 4 Withdrawn Karolinska Institutet
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).

Timeline

Start
2010-11-10
Primary completion
2010-12-11
Completion
2010-12-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 50 mg Oral
Subject Etoricoxib Small molecule 120 mg

Indications